Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Post by PLITheOneon Apr 13, 2021 8:46am
42 Views
Post# 32983751

Really

Really

They have FDA approval. Doubt it, that's not part of the plan. Didn't finish check points! Manufacturing not audited and approved. Scientists gone! This will go nowhere.Liminal has no money, nobody outside of Thomvest influence will touch this now. You do realize that they are facing a lawsuit 7x market cap. They are going to zero! Buy more dumbazz!

Vocher isn't a done deal dufice! Wait till Americans investors and SEC find out what Thomvest is doing. 

<< Previous
Bullboard Posts
Next >>